QNRX · Quoin Pharmaceuticals Ltd. · Financials
$6.79
-0.11 (-1.59%)
At close · Sep 11
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based upon the Company's current business plans and cash, cash equivalents, and investments on hand, management has concluded that there is substantial doubt about the Company's ability to continue as a going concern for a period of at least one year from the date of the filing of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 14, 2026
Market Cap
$13.64M
Shares
2.01M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$0
FY2021
Diluted EPS
-$52.50
+98.6%
FY2021
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | $0 | $0 | $0 | |
| $6.71M | $6.49M | $5.93M | $6.07M | $6.58M | $4.5M | $1.43M | $1.51M | |
| $100K | $100K | $100K | $103.71K | $104.04K | $104.04K | $104.04K | $20.71K | |
| $479.83K | $486.06K | $565.99K | $691.93K | -$123.79K | -$15.4M | -$425.35K | — | |
| — | -$15.8M | -$8.96M | — | — | — | — | — | |
| — | — | — | -$8.69M | -$9.45M | -$21.46M | — | — | |
| — | -$15.81M | -$8.96M | — | — | — | — | — | |
| USD/shares | — | — | — | — | — | -$52.50 | -$3,675.00 | -$2,730.00 |
| USD/shares | — | — | — | — | — | -$52.50 | -$3,675.00 | -$2,730.00 |
| shares | — | — | — | — | — | 301.89K | 228.85K | 228.85K |
| shares | — | — | — | — | — | 301.89K | 228.85K | 228.85K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.